New drugs in the treatment of Hodgkin's disease.

Abstract

In the treatment of Hodgkin's disease (HD) remission rates of 80% have been achieved with combination regimens such as COPP/ABVD; 30%-50% of these patients relapse, however, and less than 25% of those in first relapse can be cured. Although 90% of adults with advanced Hodgkin's disease (HD) achieve a complete remission with new polychemotherapy regimens such as BEACOPP, it is too early to assess how many patients ultimately can be cured. In addition, these regimens are associated with severe side effects including infertility, cardiomyopathy or second malignancies. Thus, alternative strategies for improving the outcome of patients with HD have been developed. These approaches include new cytostatic drugs and biological agents. Here, we review the most recent developments including the new vinca alkaloid vinorelbine, the anthracycline idarubicin, the nitrogen mustard bendamustine, the recently developed nucleoside analogue gemcitabine, and immunotoxins against Hodgkin/Reed-Sternberg cells. We conclude that current polychemotherapy regimens could possibly be improved by introducing new agents with a different mechanism of action such as gemcitabine. In addition, some of these new drugs including gemcitabine or vinorelbine could contribute to the reduction of toxic side effects, thus resulting in an improved quality of life for patients with HD.

• Authors: P Borchmann, R Schnell, V Diehl, A Engert
• Journal: Annals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 9 Suppl 5 Pg. S103-8 ( 1998) ISSN: 0923-7534 [Print] England
• PMID: 9926247 (Publication Type: Journal Article, Review)

Chemical References

• Antibiotics, Antineoplastic
• Antimetabolites, Antineoplastic
• Antineoplastic Agents
• Antineoplastic Agents, Phytogenic
• Immunotoxins
• Nitrogen Mustard Compounds
• Deoxycytidine
• Vinblastine
• Bendamustine Hydrochloride
• Vinorelbine
• Idarubicin
• Gemcitabine

Topics

• Adult
• Antibiotics, Antineoplastic (therapeutic use)
• Antimetabolites, Antineoplastic (therapeutic use)
• Antineoplastic Agents (therapeutic use)
• Antineoplastic Agents, Phytogenic (therapeutic use)
• Bendamustine Hydrochloride
• Deoxycytidine (analogs & derivatives, therapeutic use)
• Drug Therapy (trends)
• Hodgkin Disease (drug therapy, pathology)
• Humans
• Idarubicin (therapeutic use)
• Immunotoxins (therapeutic use)
• Nitrogen Mustard Compounds (therapeutic use)
• Vinblastine (analogs & derivatives, therapeutic use)
• Vinorelbine
• Gemcitabine